Page last updated: 2024-08-17

apomorphine and naxagolide

apomorphine has been researched along with naxagolide in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19905 (35.71)18.7374
1990's6 (42.86)18.2507
2000's2 (14.29)29.6817
2010's1 (7.14)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dijkstra, D; Horn, AS; Mulder, TB; Rollema, H; Tepper, PG; Van der Weide, J1
Diederich, NJ; Goetz, CG1
Lawrence, MS; Redmond, DE1
Boyce, S; Iversen, SD; Rupniak, NM; Steventon, MJ1
Barth, TM; Dourish, CT; Iversen, SD; Martin-Iverson, MT; Stoessl, AJ1
Jones, JH; Lotti, VJ; Martin, GE; Pettibone, DJ; Taylor, DA; Williams, M; Zrada, MM1
Czuczwar, SJ; Löscher, W1
Clineschmidt, BV; Jones, JH; Martin, GE; Pettibone, DJ; Williams, M; Yarbrough, GG1
Herrero, MT; Laguna, J; Luquin, MR; Obeso, JA1
Day, J; Fibiger, HC1
Ashmeade, T; Routledge, C; Taylor, S; Thorn, L1
Else, D; Martin-Iverson, MT1
Seeman, P1
Ding, M; Dorff, P; Elmore, CS; Maier, D; Malmquist, J; Mrzljak, L; Peng, T; Ström, P; Tuke, D; Werkheiser, J; Widzowski, D; Zysk, J1

Reviews

1 review(s) available for apomorphine and naxagolide

ArticleYear
Dopaminergic agonists in the treatment of Parkinson's disease.
    Neurologic clinics, 1992, Volume: 10, Issue:2

    Topics: Apomorphine; Bromocriptine; Dopamine Agents; Humans; Lactose; Lisuride; Methylcellulose; Oxazines; Parkinson Disease; Pergolide; Receptors, Dopamine

1992

Other Studies

13 other study(ies) available for apomorphine and naxagolide

ArticleYear
Synthesis and pharmacology of trans-4-n-propyl-3,4,4a,10b-tetrahydro-2H,5H-1-benzopyrano[4,3-b ]-1,4-oxazin-7- and -9-ols: the significance of nitrogen pKa values for central dopamine receptor activation.
    Journal of medicinal chemistry, 1988, Volume: 31, Issue:11

    Topics: Animals; Benzopyrans; Binding Sites; Brain Chemistry; Cattle; Dopamine; Dopamine Agents; Nitrogen; Oxazines; Protons; Rats; Receptors, Dopamine

1988
MPTP lesions and dopaminergic drugs alter eye blink rate in African green monkeys.
    Pharmacology, biochemistry, and behavior, 1991, Volume: 38, Issue:4

    Topics: Animals; Apomorphine; Blinking; Chlorocebus aethiops; Dopamine Agents; Haloperidol; Male; MPTP Poisoning; Oxazines; Parkinson Disease; Receptors, Dopamine; Substantia Nigra; Sulpiride

1991
Differential effects of D1 and D2 agonists in MPTP-treated primates: functional implications for Parkinson's disease.
    Neurology, 1990, Volume: 40, Issue:6

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Behavior, Animal; Benzazepines; Dyskinesia, Drug-Induced; Levodopa; Male; Motor Activity; Oxazines; Parkinson Disease, Secondary; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Saimiri

1990
Effects of ageing on the behavioural responses to dopamine agonists: decreased yawning and locomotion, but increased stereotypy.
    Brain research, 1989, Aug-21, Volume: 495, Issue:1

    Topics: Aging; Animals; Apomorphine; Dopamine Agents; Male; Motor Activity; Oxazines; Rats; Rats, Inbred Strains; Stereotyped Behavior; Yawning

1989
Selectivity of (+)-4-propyl-9-hydroxynaphthoxazine [(+)-PHNO] for dopamine receptors in vitro and in vivo.
    The Journal of pharmacology and experimental therapeutics, 1985, Volume: 233, Issue:2

    Topics: Animals; Apomorphine; Cats; Clonidine; Ergolines; In Vitro Techniques; Lisuride; Male; Muscle Contraction; Mydriatics; Oxazines; Pergolide; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Receptors, Dopamine; Receptors, Serotonin; Serotonin; Vas Deferens

1985
Studies on the involvement of dopamine D-1 and D-2 receptors in the anticonvulsant effect of dopamine agonists in various rodent models of epilepsy.
    European journal of pharmacology, 1986, Aug-22, Volume: 128, Issue:1-2

    Topics: Animals; Anticonvulsants; Apomorphine; Female; Gerbillinae; Kindling, Neurologic; Levodopa; Lisuride; Male; Mice; Oxazines; Rats; Receptors, Dopamine; Stimulation, Chemical

1986
Pharmacologic profile of a novel potent direct-acting dopamine agonist, (+)-4-propyl-9-hydroxynaphthoxazine [(+)-PHNO].
    The Journal of pharmacology and experimental therapeutics, 1984, Volume: 230, Issue:3

    Topics: Adenylyl Cyclases; Animals; Apomorphine; Binding, Competitive; Body Temperature; Brain Stem; Female; Fishes; Humans; Hydroxydopamines; Mice; Motor Activity; Oxazines; Oxidopamine; Posture; Rats; Rats, Inbred Strains; Receptors, Dopamine; Retina; Spiperone; Stereotyped Behavior; Vomiting

1984
Behavioral tolerance to repeated apomorphine administration in parkinsonian monkeys.
    Journal of the neurological sciences, 1993, Volume: 114, Issue:1

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Apomorphine; Behavior, Animal; Dopamine; Dopamine Agents; Drug Tolerance; Female; Macaca fascicularis; Male; MPTP Poisoning; Oxazines; Parkinson Disease, Secondary; Psychomotor Performance

1993
Dopaminergic regulation of cortical acetylcholine release: effects of dopamine receptor agonists.
    Neuroscience, 1993, Volume: 54, Issue:3

    Topics: Acetylcholine; Animals; Apomorphine; Benzazepines; Cerebral Cortex; Dialysis; Dopamine; Dopamine Agents; Dopamine D2 Receptor Antagonists; Ergolines; Indoles; Male; Nerve Endings; Oxazines; Phenanthridines; Quinpirole; Raclopride; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Salicylamides

1993
Elucidation of D3 receptor function in vivo: do D3 receptors mediate inhibition of dopamine neuronal activity?
    Biochemical Society transactions, 1996, Volume: 24, Issue:1

    Topics: Animals; Apomorphine; Corpus Striatum; Dopamine; Dopamine Agonists; Ergolines; Male; Mice; Mice, Inbred Strains; Microdialysis; Neurons; Nucleus Accumbens; Oxazines; Quinolines; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Dopamine D3; Tetrahydronaphthalenes

1996
PHNO, a selective dopamine D2 receptor agonist, does not reduce prepulse inhibition of the startle reflex in rats.
    Psychopharmacology, 2000, Volume: 151, Issue:1

    Topics: Analysis of Variance; Animals; Apomorphine; Dopamine Agonists; Male; Oxazines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Reflex, Startle

2000
Antiparkinson therapeutic potencies correlate with their affinities at dopamine D2(High) receptors.
    Synapse (New York, N.Y.), 2007, Volume: 61, Issue:12

    Topics: Animals; Antiparkinson Agents; Apomorphine; Benzazepines; Binding, Competitive; Corpus Striatum; Domperidone; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Oxazines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Statistics as Topic; Tritium

2007
D2 receptor occupancy in conscious rat brain is not significantly distinguished with [3H]-MNPA, [3H]-(+)-PHNO, and [3H]-raclopride.
    Synapse (New York, N.Y.), 2010, Volume: 64, Issue:8

    Topics: Animals; Apomorphine; Binding Sites; Binding, Competitive; Brain; CHO Cells; Cricetinae; Cricetulus; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Male; Oxazines; Raclopride; Rats; Rats, Long-Evans; Receptors, Dopamine D2; Receptors, G-Protein-Coupled

2010